Literature DB >> 3558856

Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.

E A Macintyre, B Vaughan Hudson, G Vaughan Hudson, A M Jelliffe, D C Linch.   

Abstract

A retrospective study of 136 bone marrow aspirates was undertaken before treatment to evaluate the importance of bone marrow eosinophilia in Hodgkin's disease. This occurred in 28 patients (21%) but did not correlate with age, sex, B symptoms, histopathological type or peripheral blood count. It also had no effect on survival. Bone marrow eosinophilia, therefore, seems to represent a common but non-specific reaction to Hodgkin's disease.

Entities:  

Mesh:

Year:  1987        PMID: 3558856      PMCID: PMC1140891          DOI: 10.1136/jcp.40.3.245

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Analysis of grade 1 Hodgkin's disease (Report no 6).

Authors:  M H Bennett; A Tu; G V Hudson
Journal:  Clin Radiol       Date:  1981-09       Impact factor: 2.350

2.  Eosinophilia and plasmacytosis of the bone marrow in Hodgkin's disease.

Authors:  L Kass; M L Votaw
Journal:  Am J Clin Pathol       Date:  1975-08       Impact factor: 2.493

  2 in total
  1 in total

1.  Comparison of eosinophil density in staging bone marrow biopsies from Malawi and the United States.

Authors:  Nathan D Montgomery; Tiffany Graham; Robert Krysiak; Coxcilly Kampani; N George Liomba; Satish Gopal; Yuri Fedoriw
Journal:  Pathol Int       Date:  2015-06-08       Impact factor: 2.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.